期刊文献+

急性心肌梗死合并心源性休克或血流动力学紊乱患者应用主动脉内球囊反搏术后影响临床疗效的危险因素分析 被引量:24

Analysis of influencing factors of intra-aortic balloon counter pulsation on patients with cardiac shock or hemodynamic disorder after acute myocardial infarction
下载PDF
导出
摘要 目的探讨急性心肌梗死(AMI)合并心源性休克(CS)或血流动力学紊乱患者应用主动脉内球囊反搏术(IABP)辅助治疗后,影响临床疗效的危险因素。方法回顾性分析广州军区广州总医院68例因AMI合并CS或血流动力学紊乱应用IABP辅助治疗的患者,根据其临床转归分为好转、死亡两组。对两组的性别、年龄、高血压、糖尿病、吸烟、高脂血症、既往冠心病史、入院时心率、入院时收缩压、入院时舒张压、病变血管支数、发病至行IABP术时间、TIMI血流、罪犯血管14项进行Logistic回归分析。结果本研究的死亡率为47.06%,所有危险因素中,罪犯血管是影响临床疗效的独立危险因素(P=0.015),其余危险因素均未影响预后(P〉0.05)。罪犯血管组间比较显示,前降支与其他罪犯血管间差异有统计学意义(OR 0.047,95%CI 0.004~0.547,P=0.015)。结论罪犯血管是AMI合并CS或血流动力学紊乱应用IABP辅助治疗后影响临床疗效的危险因素。前降支病变患者应用IABP辅助治疗后可降低住院期间死亡率,左主干、右冠状动脉病变患者应用IABP辅助治疗后未能降低住院期间死亡率。 Objective To explore the influencing factors of clinical outcomes in patients with cardiac shock( CS) or hemodynamic disorder after acute myocardial infarction( AMI) with application of intra-aortic balloon counter pulsation( IABP) adjuvant therapy. Methods Retrospective analysis of 68 patients with CS or hemodynamic disorder after AMI with application of IABP adjuvant therapy was made.The patients were devided into the surivival group( n = 36) and the deceased group( n = 32) according to their clinical outcome. Logistic regression analysis of sex,age,co-morbidities of hypertension,diabetes,smoking,and hyperlipidemia,history of coronary heart disease,heart rate,systolic / diastolic blood pressure,lesion blood vessel counts,time from pathogenesis to IABP placement,TIMI flow grades,culprit vessel was done between the two groups. Results The mortality rate of our study was 47. 06%. Of all the risk factors,culprit vessel is the only independent risk factor that affect the clinical prognosis( P = 0. 015),but other risk factors do not affect the clinical prognosis( P 〉 0. 05). Compared the culprit vessels,anterior descending branch was statistically different in correlation from other culprit vessels( OR 0. 047,95% CI 0. 004-0. 547,P = 0. 015). Conclusions Culprit vessel is the risk factor that affects clinical prognosis of patients with CS or hemodynamic disorder after AMI with application of IABP adjuvant therapy. Application of IABP adjuvant therapy in patients with anterior descending branch lesions can reduce the in-hospital mortality,but cannot reduce the in-hospital mortality in other calprit vessel lesions including left main or RCA lesions.
出处 《中国介入心脏病学杂志》 2014年第11期681-684,共4页 Chinese Journal of Interventional Cardiology
基金 广东省科技计划项目(2012B031800182)
关键词 急性心肌梗死 心源性休克 血流动力学紊乱 主动脉内球囊反搏术 Acute myocardial infarction Cardiac shock Hemodynamic disorder Intra-aortic balloon counter pulsation
  • 相关文献

参考文献13

  • 1Holmes DJ. Cardiogenic shock: a lethal complication of acute myocardial infarction. Rev Cardiovasc Med ,2003,4 : 131-135.
  • 2Perera D, Stables R, Thomas M, et al. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA, 2010,304: 867 -874.
  • 3崔丽丽,黄伟剑,李晟,周浩,吴高俊,李海鹰.急诊介入联合IABP治疗急性心肌梗死合并心源性休克[J].医学研究杂志,2013,42(5):163-166. 被引量:9
  • 4Ohman EM, Hochman JS. Aortic counterpulsation in acute myocardial infarction: physiologically important but does the patient benefit? Am Heart J,2001,141:889-892.
  • 5Rognoni A, Cavallino C, Lupi A, et al. Aortic counterpulsation in cardiogenic shock during acute myocardial infarction. Expert Rev Cardiovasc Ther,2014,12:913-917.
  • 6Hochman JS, Buller CE, Sleeper LA, et al. Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol,2000,36:1063-1070.
  • 7Sjauw KD,Engstrom AE, Vis MM, et al. Efficacy and timing of intra-aortic counterpulsation in patients with ST-elevation myocardial infarction complicated by cardiogenic shock. Neth Heart J ,2012,20:402-409.
  • 8Thiele H, Zeymer U, Neumann FJ, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II ) : final 12 month results of a randomised, open-label trial. Lancet,2013,382:1638-1645.
  • 9Cheng JM, den Uil CA, Hoeks SE, et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta- analysis of controlled trials. Eur Heart J,2009,30:2102-2108.
  • 10李南,韩静,冯斯婷,周玉杰.体外膜肺氧合对急性冠状动脉左主干病变的临床疗效分析[J].中国康复理论与实践,2013,19(6):589-591. 被引量:1

二级参考文献21

  • 1南开大学实验动物解剖学编写组编.实验动物解剖学[M]:第一版[M].北京:人民教育出版社,1980.23-27.
  • 2Robert J, Goldberg, Frederick A, et al. Thirty year trends ( 1975 -2005 ) in the magnitude,management,and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction :a population - based perspective[ J]. Am Heart J,2011 ,162(2): 268 -275.
  • 3Balzi D, Barchielli A, Buiatti E, et al. Effect of comorbidity on coronary reperfusion strategy and long - term mortality after acute myocardial infarction[ J]. Am Heart J ,2006 ,151(5) : 1094 - 1100.
  • 4Ohraan J EM, Nanas J,Stomel RJ, et al. Thrombolysis and counter-pulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure : results of the TACTICS Trial[J] ? Thromb Thrombolysis,2005 ,19( 1) :33 -39.
  • 5Sjauw KD, Engstrdm AE,Vis MM ,et al. Efficacy and timing of intra -aortic counterpulsation in patients with ST - elevation myocardial infarc tion complicated by cardiogenic shock [ J ]. Neth Heart J, 2012 , 20 (10) :402 -409.
  • 6Krishnan R, Michael EF, John EC , et al. Rapid complete reversal of systemic hypoperfusion following intra - aortic balloon pump counterpulsation and survival in cardiogenic shock complicating an acute myocardial infarction[J]. Am Heart J,2011,162(2) :268 -275.
  • 7Fox KA, Steg PG, Eagle KA,et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999 - 2006 [ J ] . JAMA, 2007 , 297(17) :1892 -1900.
  • 8Antman EM , Hand M, Armstrong PW, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST -elevation myocardial infarction : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guide-lines[J],J Am Coll Cardiol,2008,51 (2) :210 -247.
  • 9Sjauw KD, Engstrdm AE, Vis MM , et al. A systematic review and meta -analysis of intra - aortic balloon pump therapy in ST - elevation myocardial infarction:should we change the guidelines? [J]. Eur Heart J, 2009,30(4) :459 -468.
  • 10Bahrmann P, Rach J, Desch S, et al. Incidence and distribution of occluded culprit arteries and impact of coronary collaterals on outcome in patients with non - ST - segment elevation myocardial infarction and early invasive treatment strategy[ J]. Clin Res Cardiol, 2011 ,100(5 ): 457 -467.

共引文献25

同被引文献157

引证文献24

二级引证文献148

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部